Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > January 9th warrants

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Jan 06, 2023 10:51am

249 Views

Post# 35206798

RE:RE:RE:RE:RE:RE:RE:RE:RE:January 9th warrants

chry, with multi company big pharma interest, we are in a very enviable position. IMO the primary advantage of this is one company can't make a low-ball offer and walk away with a deal. The other interested parties will make sure of that, so we are in the enviable position of being sure we will get at least a fair value deal at resonable market value. You can't ask for more than that.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)